However, the adverse reactions of hepatotoxicity and gastrointestinal limit the clinical use of MTX (Cather and Crowley, 2014), and its combination with TNF-α mab increases the risk of reactivation of tuberculosis (Lorenzetti et al., 2014). The gene discussed is TNF; the disease is tuberculosis.